WEG
GILD icon

World Equity Group’s Gilead Sciences GILD Stock Holding History

World Equity Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,268
Closed -$239K – 291
2024
Q1 		$239K Sell
3,268
-376
-10% -$28.9K 0.05% 269
2023
Q4 		$295K Sell
3,644
-1,394
-28% -$108K 0.06% 254
2023
Q3 		$378K Buy
+5,038
New +$388K 0.08% 235
2023
Q2 		– Sell
-90,535
Closed -$1.29M – 412
2023
Q1 		$1.29M Buy
90,535
+87,083
+2,523% +$7.21M 0.19% 136
2022
Q4 		$296K Sell
3,452
-612
-15% -$48.5K 0.07% 253
2022
Q3 		$251K Buy
4,064
+607
+18% +$38.3K 0.06% 271
2022
Q2 		$214K Sell
3,457
-113
-3% -$7K 0.05% 308
2022
Q1 		$212K Buy
+3,570
New +$228K 0.05% 330

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

World Equity Group's GILD Position: Q2 2024 in Review

World Equity Group sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 3,268 shares — an estimated $239K sold.

World Equity Group first reported a position in GILD in Q1 2022 and held it in 8 quarters. The position peaked at $1.29M in Q1 2023. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • World Equity Group reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • World Equity Group sold 3,268 Gilead Sciences shares in Q2 2024, an estimated $239K.
  • World Equity Group first reported a position in Gilead Sciences in Q1 2022 and held it in 8 quarters.
  • World Equity Group's Gilead Sciences position peaked at $1.29M in Q1 2023.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on World Equity Group's 13F filing for Q2 2024, filed 18 Jul 2024.